These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 20173357)

  • 1. Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells.
    Merz PR; Röckel N; Ballikaya S; Auffarth GU; Schmack I
    BMC Ophthalmol; 2018 Dec; 18(1):316. PubMed ID: 30537942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells.
    Rusovici R; Sakhalkar M; Chalam KV
    Mol Vis; 2011; 17():3339-46. PubMed ID: 22219629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab.
    Meyer CH; Holz FG
    Eye (Lond); 2011 Jun; 25(6):661-72. PubMed ID: 21455242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells.
    Grau S; Thorsteinsdottir J; von Baumgarten L; Winkler F; Tonn JC; Schichor C
    J Neurooncol; 2011 Aug; 104(1):103-12. PubMed ID: 21308397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use.
    Yoeruek E; Spitzer MS; Saygili O; Tatar O; Biedermann T; Yoeruek E; Bartz-Schmidt KU; Szurman P
    J Cataract Refract Surg; 2008 Dec; 34(12):2139-45. PubMed ID: 19027573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.
    Yoeruek E; Spitzer MS; Tatar O; Biedermann T; Grisanti S; Lüke M; Bartz-Schmidt KU; Szurman P
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1392-7. PubMed ID: 18385055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells.
    Bayyoud T; Thaler S; Hofmann J; Maurus C; Spitzer MS; Bartz-Schmidt KU; Szurman P; Yoeruek E
    Curr Eye Res; 2012 Mar; 37(3):179-86. PubMed ID: 22335804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human anterior lens capsule as carrier matrix for cultivated human corneal endothelial cells.
    Yoeruek E; Saygili O; Spitzer MS; Tatar O; Bartz-Schmidt KU; Szurman P
    Cornea; 2009 May; 28(4):416-20. PubMed ID: 19411960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro effects of dexamethasone on cellular proliferation, apoptosis, and Na+-K+-ATPase activity of bovine corneal endothelial cells.
    Chen WL; Lin CT; Yao CC; Huang YH; Chou YB; Yin HS; Hu FR
    Ocul Immunol Inflamm; 2006 Aug; 14(4):215-23. PubMed ID: 16911983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bevacizumab on apoptosis, Na+ -K+ -adenosine triphosphatase and zonula occludens 1 expression on cultured corneal endothelial cells.
    Yoeruek E; Tatar O; Spitzer MS; Saygili O; Biedermann T; Bartz-Schmidt KU; Thaler S; Szurman P
    Ophthalmic Res; 2010; 44(1):43-9. PubMed ID: 20173357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal regulation of Na+/K+-dependent ATPase activity and pump function in corneal endothelial cells.
    Hatou S
    Cornea; 2011 Oct; 30 Suppl 1():S60-6. PubMed ID: 21912233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal Endothelial Cells Over the Past Decade: Are We Missing the Mark(er)?
    Van den Bogerd B; Zakaria N; Adam B; Matthyssen S; Koppen C; Ní Dhubhghaill S
    Transl Vis Sci Technol; 2019 Nov; 8(6):13. PubMed ID: 31772824
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.